Eradicating the use of
Antibiotics Globally
40 years of Peptide Scientific R&D Catalysed by AI replacing antibiotics globally
Sustainable solutions powered by advanced AI.
Mission Statement
PHYTOCYTE’s mission is using AI to build on 40 years of scientific research developing advanced Antimicrobial Peptides and next-generation biotechnology to replace the use of antibiotics in the global food, and animal health food chains.
We design development strategies that eradicate the need for in-feed antibiotics enhance animal health, and reduce antibiotic dependency across aquaculture, agriculture, and livestock production systems.
Our technology integrates optimization of structural parameters, sequence modification, and nano-delivery systems to deliver scalable, safe, and effective alternatives that protect ecosystems and reinforce global food security.
Within 10 years we anticipate developing antimicrobial peptides to replace the use of antibiotics for human use.
Antimicrobial peptides
Animal health
Replace antibiotics
Food security
PhytoCyte Pty Ltd
PhytoCyte is an emerging biosciences company developing a new generation of Antimicrobial Peptides (AMPs), designed to address the growing global demand for alternatives to traditional antibiotics. The company has already demonstrated successful applications in aquaculture and is now progressing into veterinary trials for poultry and livestock, while expanding into food preservation, disinfectants, agriculture, and future human health applications.
In parallel, PhytoCyte is building a broader biotechnology platform through strategic acquisitions and advanced cannabinoid technologies developed for laboratory production. Through a proposed transaction with Bakhu Holdings Company, PhytoCyte aims to establish a globally focused bioscience and technology group with planned expansion across Asia-Pacific and international capital markets.
The group is currently advancing multiple acquisition opportunities in Hong Kong, Singapore, and Australia, while pursuing an uplisting strategy toward NASDAQ to support long-term growth, liquidity, and global investor access.
Where AMP technology creates value
PhytoCyte focuses on sectors where reducing antibiotic dependence and improving biological performance are becoming global priorities.
Aquaculture
Supporting sustainable disease control in shrimp and fish farming.
Agriculture
Our aim is to combat HLB in citrus and Fusarium, as well as to provide a solution for plant biostimulation.
Livestock Veterinary
Future veterinary applications developed from the AMP technology platform.
Long-Term Vision
Human Health
Long-term development of AMP-based solutions for human healthcare applications, building on the same peptide technology platform.
To commercialise PHYTOCYTE technology and establish it as trusted, science-driven partner in global animal health and the worlds food chain
Innovate
- Advance peptide platform for targeted antimicrobial solutions.
- Accelerate peptide sequence design and nano-delivery formulation using artificial intelligence
Scale
- Expand commercial trials across poultry, livestock, and agriculture.
- Implement high-efficiency production frameworks for global supply.
Expand
- Establish strategic footprints across Asia-Pacific and North America.
- Pursue international capital market listings and partnerships.